Revascularization in Stable Coronary Artery Disease: a Combined Perspective from an Interventional Cardiologist and a Cardiac Surgeon

Overview

Journal Eur Heart J

Publisher Oxford University Press

Specialty Cardiology & Vascular Diseases

Date 2016 Mar 20

PMID 26994152

Citations 3

Authors

David R Holmes Jr

David P Taggart

Affiliations

Soon will be listed here.

Abstract

It is now half a century since the start of coronary bypass graft surgery (CABG) with the first percutaneous coronary intervention (PCI) following just over a decade later. The relative merits of PCI vs. CABG for stable coronary artery disease (stable-CAD) have continued to be debated ever since and have been the focus of around 20 randomized trials and numerous registry studies, systematic reviews, and meta-analyses. The aim of this review is to identify areas of agreement, disagreement, and uncertainties in the role of PCI and CABG in patients with stable-CAD.

Citing Articles

A TEMPOL and rapamycin loaded nanofiber-covered stent favors endothelialization and mitigates neointimal hyperplasia and local inflammation.

Wang R, Lu J, Yin J, Chen H, Liu H, Xu F Bioact Mater. 2022; 19:666-677.

PMID: 35600979 PMC: 9114161. DOI: 10.1016/j.bioactmat.2022.04.033.

Short- and Long-Term Prognosis of Intravascular Ultrasound-Versus Angiography-Guided Percutaneous Coronary Intervention: A Meta-Analysis Involving 24,783 Patients.

Zhang Q, Wang B, Han Y, Sun S, Lv R, Wei S J Interv Cardiol. 2021; 2021:6082581.

PMID: 34737679 PMC: 8536416. DOI: 10.1155/2021/6082581.

Profiles of Hospitalized Patients with Angiographic Coronary Heart Disease in Taiwan during 2014-2016: Report of a Tertiary Hospital.

Lin W, Hung Y, Lin G, Lin C, Liou J, Cheng C Acta Cardiol Sin. 2021; 37(4):365-376.

PMID: 34257486 PMC: 8261704. DOI: 10.6515/ACS.202107_37(4).20210118F.